A systematic review, examining the relationship between levels of cholesterol and markers of cholesterol turnover and MS disease outcomes, suggests that elevated levels of circulating LDL-C, TC, and particularly ApoB are associated with adverse clinical and MRI outcomes in MS [73]. Here, APOB is linked to myeloid sarcoma.